Big Move For Stemline Therapeutics, Inc.

Mon 04 May 20 at 05:30 PM
Big Move For Stemline Therapeutics, Inc.

Stemline Therapeutics, Inc. (STML:NASDAQ) rocketted at $12.11, a gain of 154.8%. On Fri 01 May 20, STML:NASDAQ touched a New 2-Week Low of $4.75. The stock got featured on our News Catalysts scanner on Sat 02 May 20 at 04:57 AM in the 'EARNINGS' category. From Fri 17 Apr 20, the stock recorded 50.00% Up Days and 54.55% Green Days

The share price of the company has been moving sideways in recent weeks.

About Stemline Therapeutics, Inc. (STML:NASDAQ)

Stemline Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.

Share